自组装的Baicalein-Resveratrol纳米医学协同调节多个途径,以缓解病原体诱导的肺炎
Fuyun Chi1,2, Kaixin Liu1, Jin Yan1
1State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China.
这项研究引入了结合Baicalein和Resveratrol治疗肺炎的新型纳米颗粒. 这些纳米颗粒向肺巨细胞,提供了对抗耐药病原体的有希望的多动作疗法.
科学领域:
- 纳米医学是一种纳米医学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 病原体诱导的肺炎对全球健康构成重大风险,患病率和死亡率高.
- 传统的抗生素因抗菌素耐药性和有效性有限而面临挑战.
- 迫切需要针对肺炎多种机制的创新疗法.
研究的目的:
- 开发一种无载体纳米药物,可同时提供Baicalein (BAI) 和Resveratrol (RES) 用于肺炎治疗.
- 创建稳定的BAI-RES纳米粒子 (BRNP) 具有增强的溶解性和治疗潜力.
- 调查BR NPs的协同药理活性和治疗益处.
主要方法:
- 自组装方法将BAI和RES制成稳定的BR纳米粒子.
- 使用病原体感染的小鼠进行体内研究,以评估纳米粒子积累和药物释放.
- 分析炎症和免疫反应的调节,包括巨细胞两极分化,中性粒细胞透和氧化应激.
主要成果:
- BR NPs在感染小鼠的肺巨中表现出偏好的积累.
- 在炎症微环境中观察到pH响应的药物释放.
- 通过调节关键信号通路 (Toll-like受体,TNF,HIF-1),BR NPs有效抑制了M1巨细胞的两极分化,减少了中性粒细胞的透,并减轻了氧化应激.
结论:
- 无载体的BR纳米粒子表现出协同效应,巨细胞向和受控释放特性.
- BR NPs为肺炎提供了多目标和多途径的治疗效益.
- 这种纳米药物为治疗病原体引起的肺炎提供了一种新且有前途的策略.
更多相关视频
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
相关概念视频
13:45A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
07:59A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:51High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
